Skip to main content

Metabolism

1
Pipeline Programs
3
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

3 companies ranked by most advanced pipeline stage

AstraZeneca
AstraZenecaCAMBRIDGE, United Kingdom
1 program
1
AZD3480Phase 11 trial
Active Trials
NCT00692510Completed18Est. Sep 2008
Colorado Therapeutics
Colorado TherapeuticsCO - Louisville
1 program
CannabidiolN/A1 trial
Active Trials
NCT04971837Completed26Est. Dec 2021
Enterprise Therapeutics
1 program
NEAAN/A1 trial
Active Trials
NCT05020808Completed33Est. Jun 2022

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
AstraZenecaAZD3480
Enterprise TherapeuticsNEAA
Colorado TherapeuticsCannabidiol

Clinical Trials (3)

Total enrollment: 77 patients across 3 trials

Drug Interaction Study Between AZD3480 and Cytochrome P450

Start: Nov 2007Est. completion: Sep 200818 patients
Phase 1Completed

The Effect of a Plant Protein Isolate on Muscle Protein Synthesis in Humans at Rest and After Resistance Exercise

Start: Sep 2021Est. completion: Jun 202233 patients
N/ACompleted

Interaction Between Cannabidiol, Meal Ingestion, and Liver Function

Start: May 2021Est. completion: Dec 202126 patients
N/ACompleted

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

3 companies competing in this space

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.